Dr. Ravindra Rao, MD - All India Institute of Medical Sciences - Associate Professor

Dr. Ravindra Rao

MD

All India Institute of Medical Sciences

Associate Professor

New Delhi, Delhi | India

Main Specialties: Addiction Psychiatry

Additional Specialties: Addiction Sciences

ORCID logohttps://orcid.org/0000-0002-1765-1462

Dr. Ravindra Rao, MD - All India Institute of Medical Sciences - Associate Professor

Dr. Ravindra Rao

MD

Introduction

Primary Affiliation: All India Institute of Medical Sciences - New Delhi, Delhi , India

Specialties:

Additional Specialties:

Research Interests:

Education

Jul 2001 - Jul 2004
All India Institute of Medical Sciences
MD
Psychiatry

Experience

Jun 2010 - Jun 2012
United Nations Office on Drugs and Crime, Regional Office for South Asia
Technical Officer (Drugs and HIV)
Aug 2007 - Jun 2010
National AIDS Control Organisation, Ministry of Health and Family Welfare
Programme Officer (Injecting Drug Use)
All India Institute of Medical Sciences
Associate Professor (Psychiatry)
National Drug Dependence Treatment Centre, Department of Psychiatry

Publications

23Publications

173Reads

30Profile Views

25PubMed Central Citations

Rates, knowledge and risk factors of non-fatal opioid overdose among people who inject drugs in India: A community-based study.

Drug Alcohol Rev 2020 01 25;39(1):93-97. Epub 2019 Nov 25.

National AIDS Control Organisation, New Delhi, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dar.13016DOI Listing
January 2020

Use of Filter Paper to Measure Alcohol Biomarkers among Opioid-Dependent Patients on Agonist Maintenance Treatment: A Community-Based Study.

Indian J Psychol Med 2019 Nov-Dec;41(6):529-534. Epub 2019 Nov 11.

National Drug-Dependence Treatment Centre and Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/IJPSYM.IJPSYM_304_19DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875832PMC
November 2019

Field Testing of ICD-11 Proposals for Female Sexual Dysfunctions in India: Cognitive Interviews with Patients.

Arch Med Res 2019 11 13;50(8):567-576. Epub 2020 Feb 13.

Department of Psychiatry and Global Mental Health Program, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.arcmed.2020.01.002DOI Listing
November 2019
2.406 Impact Factor

Does Cannabis Use Influence Opioid Outcomes and Quality of Life Among Buprenorphine Maintained Patients? A Cross-sectional, Comparative Study.

J Addict Med 2018 Jul/Aug;12(4):315-320

All India Institute of Medical Sciences, New Delhi, India (IB, RR, AA); Western Sydney Local Health District, North Parramatta, NSW, Australia (VK).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/ADM.0000000000000406DOI Listing
October 2019
4 Reads
1 Citation
1.705 Impact Factor

Are non-injecting opioid users at risk of transition to injecting drug use? A multi-site study from India.

Asian J Psychiatr 2019 Apr 26;42:79-84. Epub 2019 Mar 26.

National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajp.2019.03.017DOI Listing
April 2019
3 Reads

Mental Healthcare Act, 2017, and addiction treatment: Potential pitfalls and trepidations.

Indian J Psychiatry 2019 Mar-Apr;61(2):208-212

Department of Psychiatry, National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_463_18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425793PMC
April 2019
3 Reads

Assessment of Subjective Sleep Problems in Men With Opioid Dependence Maintained on Buprenorphine.

J Addict Med 2020 Mar/Apr;14(2):132-138

National Drug Dependence Treatment Centre, Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India (RT, AD, RR, AKM, RJ, SS); Department of Medicine, All India Institute of Medical Sciences, New Delhi, India (SS).

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=01271255-900000000-9935
Publisher Site
http://dx.doi.org/10.1097/ADM.0000000000000539DOI Listing
April 2019
16 Reads
1.705 Impact Factor

Research on opioid substitution therapy in India: A brief, narrative review.

Indian J Psychiatry 2018 Jul-Sep;60(3):265-270

National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.

View Article

Download full-text PDF

Source
http://www.indianjpsychiatry.org/text.asp?2018/60/3/265/2433
Publisher Site
http://dx.doi.org/10.4103/psychiatry.IndianJPsychiatry_385_18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201667PMC
November 2018
14 Reads

Use of opium containing herbal drug and associated mania.

Asian J Psychiatr 2018 Aug 21;36:36-37. Epub 2018 Jun 21.

Department of Psychiatry & National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18762018183058
Publisher Site
http://dx.doi.org/10.1016/j.ajp.2018.06.006DOI Listing
August 2018
5 Reads

An Observational Study of Treatment Seeking Users of Natural Opiates from India.

Subst Use Misuse 2018 06 8;53(7):1139-1145. Epub 2017 Dec 8.

a National Drug Dependence Treatment Centre , Department of Psychiatry, All India Institute of Medical Sciences , New Delhi , India.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/10826084.2017.1
Publisher Site
http://dx.doi.org/10.1080/10826084.2017.1400564DOI Listing
June 2018
24 Reads
1.230 Impact Factor

Pattern of Drug Use and Associated Behaviors Among Female Injecting Drug Users From Northeast India: A Multi-Centric, Cross-Sectional, Comparative Study.

Subst Use Misuse 2015 6;50(10):1332-40. Epub 2015 Oct 6.

b United Nations Office on Drugs and Crime , Chanakyapuri , New Delhi , India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10826084.2015.1013130DOI Listing
August 2016
14 Reads
1 Citation
1.230 Impact Factor

Misuse of prescription opioids in chronic non-cancer pain.

Natl Med J India 2015 Nov-Dec;28(6):284-5

Department of Psychiatry, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India.

View Article

Download full-text PDF

Source
August 2016
3 Reads
2 Citations

Factors Affecting Drug Use During Incarceration: A Cross-Sectional Study of Opioid-Dependent Persons from India.

J Subst Abuse Treat 2016 Feb 21;61:13-7. Epub 2015 Sep 21.

National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jsat.2015.08.009DOI Listing
February 2016
26 Reads

Type of opioids injected: does it matter? A multicentric cross-sectional study of people who inject drugs.

Drug Alcohol Rev 2015 Jan 10;34(1):97-104. Epub 2014 Oct 10.

National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dar.12208DOI Listing
January 2015
17 Reads
4 Citations

The trajectory of methadone maintenance treatment in Nepal.

Int J Drug Policy 2013 Nov 8;24(6):e57-60. Epub 2013 Jul 8.

United Nations Office on Drugs and Crime-Regional Office for South Asia, New Delhi, India. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drugpo.2013.06.001DOI Listing
November 2013
3 Reads
2 Citations

India's National Narcotic Drugs and Psychotropic Substances policy, 2012: a 20th century document in the 21st century.

Int J Drug Policy 2013 Jul 4;24(4):374-5. Epub 2013 Feb 4.

National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi 110 029, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drugpo.2013.01.001DOI Listing
July 2013
14 Reads
1 Citation

The development of Methadone Maintenance Treatment in the Maldives.

Int J Drug Policy 2013 Mar 9;24(2):164-5. Epub 2012 Aug 9.

National Drug Agency (NDA), Maldives.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drugpo.2012.07.003DOI Listing
March 2013
12 Reads
2 Citations

Delivery models of opioid agonist maintenance treatment in South Asia: a good beginning.

Bull World Health Organ 2013 Feb;91(2):150-3

National Drug Dependence Treatment Centre and Department of Psychiatry, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India 110029.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2471/BLT.12.111815DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605011PMC
February 2013
4 Reads
7 Citations
5.090 Impact Factor

Ziprasidone-induced tardive dyskinesia in a patient without known risk factors.

Natl Med J India 2007 Sep-Oct;20(5):271-2

View Article

Download full-text PDF

Source
February 2008
1 Read
1 Citation

Psychiatric morbidity in HIV-infected children

AIDS Care. 2007 Jul;19(6):828-33

AIDS care

After the introduction of antiretroviral therapy, HIV infection in children has been transformed from an acute to a chronic illness. The number of HIV-infected children has also increased in recent years. The routes of transmission and clinical manifestation of HIV infection in children are unique and different from those of adults. There are a number of biological, psychological and social factors associated with HIV-infected child that may predispose him/her to develop psychiatric illness. However, there are very few studies on psychiatric morbidity in HIV-infected children. In the existing studies, a number of psychiatric illnesses including: depression, anxiety, disruptive disorders and hyperactive disorders have been observed in HIV-infected children. A number of variables have a bearing on psychiatric morbidity, including experience and expression of physical illness as well as adherence to medications. The physician dealing with HIV-infected children should be aware of the psychological manifestations so that appropriate interventions and referral may be made as needed.

View Article
July 2007
4 Reads

Baclofen-induced psychosis

Ann Pharmacother. 2006 Nov;40(11):2071-3

Annals of Pharmacotherapy

OBJECTIVE: To report a case of psychosis induced by therapeutic doses of baclofen. CASE SUMMARY: A 32-year-old Hindu man was prescribed oral baclofen 10 mg twice daily for relief of muscular spasms secondary to tetanus. After 4 weeks of baclofen use, he presented to the psychiatry emergency facility with a 4 day history of third-person auditory hallucinations and persecutory and referential delusions without underlying mood symptoms. These symptoms resolved within 1 week of discontinuing baclofen. Rechallenge with baclofen resulted in reemergence of psychotic symptoms, which disappeared after discontinuing baclofen. DISCUSSION: Reemergence of psychotic symptoms after rechallenge with baclofen suggests baclofen-induced psychosis. Use of the Naranjo probability scale indicates a probable association of baclofen with this patient's psychosis. The absence of underlying mood disorder makes this case different from previously reported ones. CONCLUSIONS: Baclofen may be associated with the occurrence of psychosis. Clinicians should consider baclofen-induced psychosis as a differential diagnosis in patients presenting with psychosis during treatment with this drug.

View Article
November 2006
5 Reads

Lomotil dependence: a note of caution.

Natl Med J India 2005 Nov-Dec;18(6):330-1

View Article

Download full-text PDF

Source
April 2006
6 Reads
3 Citations

Biochemical measures in the diagnosis of alcohol dependence using discriminant analysis.

Indian J Med Sci 2005 Oct;59(10):423-30

National Drug Dependence Treatment Centre, Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0019-5359.17048DOI Listing
October 2005
4 Reads
1 Citation

Top co-authors

Atul Ambekar
Atul Ambekar

All India Institute of Medical Sciences

12
Alok Agrawal
Alok Agrawal

East Tennessee State University

10
Ashwani Mishra
Ashwani Mishra

All India Institute of Medical Sciences

3
Arpit Parmar
Arpit Parmar

All India Institute of Medical Sciences

3
Kunal Kishore
Kunal Kishore

Gyan Vihar School of Pharmacy

3
Anju Dhawan
Anju Dhawan

All India Institute of Medical Sciences

2
Raka Jain
Raka Jain

All India Institute of Medical Sciences

2
Ashwani Kumar Mishra
Ashwani Kumar Mishra

Safdarjung Hospital Campus

2
Rishab Gupta
Rishab Gupta

John Wayne Cancer Institute

2
Pratap Sharan
Pratap Sharan

All India Institute of Medical Sciences

2